Greenleaf Trust’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-26,405
| Closed | -$2.62M | – | 592 |
|
|
2019
Q3 | $2.62M | Sell |
26,405
-1,401
| -5% | -$133K | 0.04% | 82 |
|
|
2019
Q2 | $2.57M | Sell |
27,806
-61,168
| -69% | -$5.81M | 0.04% | 86 |
|
|
2019
Q1 | $8.39M | Sell |
88,974
-263
| -0.3% | -$23K | 0.14% | 40 |
|
|
2018
Q4 | $5.72M | Sell |
89,237
-7,996
| -8% | -$590K | 0.11% | 46 |
|
|
2018
Q3 | $8.7M | Buy |
97,233
+2,827
| +3% | +$250K | 0.16% | 37 |
|
|
2018
Q2 | $7.5M | Buy |
94,406
+1,720
| +2% | +$143K | 0.14% | 40 |
|
|
2018
Q1 | $8.27M | Buy |
92,686
+3,845
| +4% | +$369K | 0.16% | 31 |
|
|
2017
Q4 | $9.27M | Sell |
88,841
-2,052
| -2% | -$232K | 0.19% | 24 |
|
|
2017
Q3 | $13.3M | Sell |
90,893
-3,241
| -3% | -$441K | 0.29% | 12 |
|
|
2017
Q2 | $12.2M | Sell |
94,134
-6,172
| -6% | -$756K | 0.28% | 13 |
|
|
2017
Q1 | $12.5M | Sell |
100,306
-17,450
| -15% | -$2.09M | 0.3% | 14 |
|
|
2016
Q4 | $13.6M | Sell |
117,756
-11,205
| -9% | -$1.25M | 0.36% | 12 |
|
|
2016
Q3 | $13.5M | Buy |
128,961
+4,321
| +3% | +$468K | 0.35% | 11 |
|
|
2016
Q2 | $12.3M | Sell |
124,640
-112,000
| -47% | -$11.6M | 0.31% | 15 |
|
|
2016
Q1 | $23.7M | Sell |
236,640
-13,996
| -6% | -$1.44M | 0.64% | 4 |
|
|
2015
Q4 | $30M | Sell |
250,636
-8,389
| -3% | -$971K | 0.91% | 2 |
|
|
2015
Q3 | $28M | Sell |
259,025
-2,705
| -1% | -$336K | 0.84% | 2 |
|
|
2015
Q2 | $30.3M | Buy |
261,730
+2,115
| +0.8% | +$242K | 0.87% | 2 |
|
|
2015
Q1 | $29.9M | Sell |
259,615
-4,772
| -2% | -$570K | 0.9% | 2 |
|
|
2014
Q4 | $29.6M | Sell |
264,387
-6,048
| -2% | -$638K | 0.86% | 2 |
|
|
2014
Q3 | $25.6M | Sell |
270,435
-1,179
| -0.4% | -$106K | 0.85% | 3 |
|
|
2014
Q2 | $23.3M | Buy |
271,614
+6,888
| +3% | +$524K | 0.74% | 5 |
|
|
2014
Q1 | $18.5M | Buy |
264,726
+59,662
| +29% | +$4.72M | 0.59% | 12 |
|
|
2013
Q4 | $17.3M | Sell |
205,064
-20,118
| -9% | -$1.59M | 0.6% | 13 |
|
|
2013
Q3 | $17.4M | Sell |
225,182
-2,224
| -1% | -$156K | 0.65% | 10 |
|
|
2013
Q2 | $13.3M | Buy |
+227,406
| New | +$13.7M | 0.52% | 9 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Greenleaf Trust's CELG Position: Q4 2019 in Review
Greenleaf Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 26,405 shares — an estimated $2.62M sold.
Greenleaf Trust first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $30.3M in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Greenleaf Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Greenleaf Trust sold 26,405 Celgene Corp shares in Q4 2019, an estimated $2.62M.
- Greenleaf Trust first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Greenleaf Trust's Celgene Corp position peaked at $30.3M in Q2 2015.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Greenleaf Trust's 13F filing for Q4 2019, filed 11 Feb 2020.